期刊文献+

Metabolic interplay between glycolysis and mitochondrial oxidation: The reverse Warburg effect and its therapeutic implication 被引量:9

Metabolic interplay between glycolysis and mitochondrial oxidation: The reverse Warburg effect and its therapeutic implication
下载PDF
导出
摘要 Aerobic glycolysis, i.e., the Warburg effect, may contribute to the aggressive phenotype of hepatocellular carcinoma. However, increasing evidence highlights the limitations of the Warburg effect, such as high mitochondrial respiration and low glycolysis rates in cancer cells. To explain such contradictory phenomena with regard to the Warburg effect, a metabolic interplay between glycolytic and oxidative cells was proposed, i.e., the "reverse Warburg effect". Aerobic glycolysis may also occur in the stromal compartment that surrounds the tumor; thus, the stromal cells feed the cancer cells with lactate and this interaction prevents the creation of an acidic condition in the tumor microenvironment. This concept provides great heterogeneity in tumors, which makes the disease difficult to cure using a single agent. Understanding metabolic flexibility by lactate shuttles offers new perspectives to develop treatments that target the hypoxic tumor microenvironment and overcome the limitations of glycolytic inhibitors. Aerobic glycolysis, i.e., the Warburg effect, may contribute to the aggressive phenotype of hepatocellular carcinoma. However, increasing evidence highlights the limitations of the Warburg effect, such as high mitochondrial respiration and low glycolysis rates in cancer cells. To explain such contradictory phenomena with regard to the Warburg effect, a metabolic interplay between glycolytic and oxidative cells was proposed, i.e., the "reverse Warburg effect". Aerobic glycolysis may also occur in the stromal compartment that surrounds the tumor; thus, the stromal cells feed the cancer cells with lactate and this interaction prevents the creation of an acidic condition in the tumor microenvironment. This concept provides great heterogeneity in tumors, which makes the disease difficult to cure using a single agent. Understanding metabolic flexibility by lactate shuttles offers new perspectives to develop treatments that target the hypoxic tumor microenvironment and overcome the limitations of glycolytic inhibitors.
出处 《World Journal of Biological Chemistry》 CAS 2015年第3期148-161,共14页 世界生物化学杂志(英文版)(电子版)
基金 Supported by Grant to Dr.Jung-Hwan Yoon the Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education,Science and Technology,No.20100007381 by the Liver Research Foundation of Korea
关键词 HEPATOCELLULAR carcinoma Oxidative stress METABOLIC interventions AEROBIC GLYCOLYSIS LACTATE Hepatocellular carcinoma Oxidative stress Metabolic interventions Aerobic glycolysis Lactate
  • 相关文献

参考文献10

  • 1Gra?yna Majkowska-Skrobek,Daria Augustyniak,Pawe? Lis,Anna Bartkowiak,Mykhailo Gonchar,Young H. Ko,Peter L. Pedersen,Andre Goffeau,Stanis?aw U?aszewski.Killing multiple myeloma cells with the small molecule 3-bromopyruvate: implications for therapy[J]. Anti-Cancer Drugs . 2014 (6)
  • 2Yao Cheng,Dongmei Diao,Hao Zhang,Qi Guo,Xuandi Wu,Yongchun Song,Chengxue Dang.High glucose?induced resistance to 5-fluorouracil in pancreatic cancercells alleviated by 2-deoxy-D-glucose[J]. Biomedical Reports . 2014 (2)
  • 3Lei Gong,Yuhua Wei,Xin Yu,Jirun Peng,Xisheng Leng.3-Bromopyruvic Acid, A Hexokinase II Inhibitor, is an Effective Antitumor Agent on the Hepatoma Cells : in vitro and in vivo Findings[J]. Anti-Cancer Agents in Medicinal Chemistry . 2014 (5)
  • 4E. M. Dunbar,B. S. Coats,A. L. Shroads,T. Langaee,A. Lew,J. R. Forder,J. J. Shuster,D. A. Wagner,P. W. Stacpoole.Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors[J]. Investigational New Drugs . 2014 (3)
  • 5Zhe Liu,Yuan-Yuan Zhang,Qian-Wen Zhang,Su-Rong Zhao,Cheng-Zhu Wu,Xiu Cheng,Chen-Chen Jiang,Zhi-Wen Jiang,Hao Liu.3-Bromopyruvate induces apoptosis in breast cancer cells by downregulating Mcl-1 through the PI3K/Akt signaling pathway[J]. Anti-Cancer Drugs . 2014 (4)
  • 6Yongjun Wang,Wei Xiang,Miao Wang,Tao Huang,Xingyuan Xiao,Liang Wang,Dan Tao,Liyun Dong,Fuqing Zeng,Guosong Jiang.Methyl jasmonate sensitizes human bladder cancer cells to gambogic acid‐induced apoptosis through down‐regulation of EZH 2 expression by miR ‐101[J]. Br J Pharmacol . 2014 (3)
  • 7Elizabeth J. Sullivan,Metin Kurtoglu,Randall Brenneman,Huaping Liu,Theodore J. Lampidis.Targeting cisplatin-resistant human tumor cells with metabolic inhibitors[J]. Cancer Chemotherapy and Pharmacology . 2014 (2)
  • 8Italo Mario Cesari,Erika Carvalho,Mariana Figueiredo Rodrigues,Bruna dos Santos Mendon?a,Nivea Dias Am?edo,Franklin David Rumjanek,Afshin Samali.Methyl Jasmonate: Putative Mechanisms of Action on Cancer Cells Cycle, Metabolism, and Apoptosis[J]. International Journal of Cell Biology . 2014
  • 9Jonathan F. Bean,Yi-Yong Qui,Songtau Yu,Sandra Clark,Fei Chu,Mary Beth Madonna.Glycolysis Inhibition and its Effect of Doxorubicin-Resistance in Neuroblastoma[J]. Journal of Pediatric Surgery . 2014
  • 10Manuel Rieber,Mary Strasberg-Rieber.p53 inactivation decreases dependence on estrogen/ERK signalling for proliferation but promotes EMT and susceptility to 3-bromopyruvate in ERα + breast cancer MCF-7 cells[J]. Biochemical Pharmacology . 2014

共引文献2

同被引文献17

引证文献9

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部